Karl Storz Power Morcellator Lawsuit Alleges Device Spread And Accelerated Uterine Cancer

January 08, 2016 – – Banville Law reports on the details of a power morcellator lawsuit filed against device manufacturer Karl Storz Endovision, Inc. The suit was filed on January 26th, 2015 in the United States District Court for the Eastern Division of Michigan under case number 2:15-cv-10352-TGB-APP. It is one of an ever-growing number of lawsuits filed against multiple power morcellator manufacturers which synonymously allege that gynecological power morcellation to remove uterine fibroids may actually cause the exposing and spreading of unknown cancer cells.

Further details of the lawsuit indicate that the woman involved underwent a hysterectomy and bilateral salpingectomy surgery in an attempt to remove bothersome uterine fibroids. For the surgery, physicians chose to use a device called a laparoscopic power morcellator. The morcellator offers a less invasive option than open surgery, and therefore a faster recovery time for the patient.

Prior to her surgery, the plaintiff was tested for cancer and results came back negative, however, shortly after undergoing laparoscopic power morcellation on her fibroids, she was diagnosed with a stage-4 cancer that had spread completely into her bones and breast tissue.

The woman alleges that when the power morcellator tool used its blades to shred her uterine fibroid tissue into small pieces to remove it from the body, it also uncovered previously undetected cancer cells and spread them throughout her body, causing a high-grade, accelerated cancer quite suddenly.

In 2014, the U.S. Food and Drug Administration issued a safety warning which discussed the use of laparoscopic power morcellation for gynecological surgeries. The warning indicated that the devices could potentially spread uterine cancer cells, and therefore women should avoid the procedure when removing uterine fibroids.

The FDA also estimated that 1 in every 350 women who currently undergo power morcellation to remove uterine fibroids may have cancer encapsulated within those uterine fibroids that both they and their physicians are completely unaware of. When cancer cells are encapsulated within a uterine fibroid, they are virtually impossible to detect without surgery. By using a power morcellator on these cancer cells, many argue that patients are significantly impacting their potential for survival.

Across the United States, power morcellator lawsuits continue to be filed. Those filed against manufacturer Ethicon have been consolidated to form multidistrict litigation number 2652 in the U.S. District of Kansas. The cases are being overseen by the Honorable Judge Kathryn H. Vratil.

In the meantime, the attorneys at Banville Law are looking to help ensure that any women who have undergone gynecological surgery with a laparoscopic power morcellator, and who were subsequently diagnosed with cancer will have the opportunity to evaluate their legal rights. These women may be entitled to legal action and compensation. Banville Law is offering free consultations to affected women at this time.

To request additional information regarding laparoscopic power morcellation, or to ask questions, please contact the attorneys at Banville Law by calling (888) 997-3792.

###

Contact Banville Law:

Laurence Banville, Esq.
888-997-3792
info@banvillelaw.com
165 West End Avenue, #1H
New York, NY 10023
United States (US)

ReleaseID: 60007047